in the pharmacokinetics of SNI-2011 in rats
single dose) gives rise to reduce body weight gain and transient neurobehavioral effects only on the day of treatment (unsteady gait
selective and orally active EGFR tyrosine kinase inhibitor
van Osch GJ
It has been demonstrated to increase the release of
Methyl-3β-hydroxycholenate Size:Contact [email protected] for quotation in the pharmacokinetics of SNI-2011Methyl 3 hydroxycholenate is a ROR gamma modulator extracted from patent US20110263046 A1, in figure 2. Product information CAS Number: 20231 57 6 Molecular Weight: 388. 58 Formula: C25H40O3 Chemical Name: methyl (4R) 4 [(1R,3aS,3bS,7S,9aR,9bS,11aR) 3a,3b,9b trihydrogenio 7 hydroxy 9a,11a dimethyl 1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH cyclopenta[a]phenanthren 1 yl]pentanoate Smiles: